Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...

A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with HIV has unearthed diagnosis "blank spots" in Africa, according to research ...

"The results of this phase 3 [AMBITION-cm] trial make it clear that this approach is just as good as the current World Health Organization-recommended first-line treatment in preventing death," first ...

Gilles van Cutsem is affiliated with Doctors Without Borders, a member of the Cryptococcal Meningitis Advocacy Group, and Chair of the Patient Advisory Committee of the slow release flucytosine ...

A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus. Ultimately, the goal is to find ways to stop deadly disease caused by ...

In a recent study published in Nature Microbiology, researchers examined metabolite-drug-fungal interactions in the fungal meningitis pathogen Cryptococcus neoformans. Antibiotic resistance refers to ...

When you have HIV/AIDS, you’re at higher risk of infections your body would normally be able to fight off. They can also be more severe, more frequent, or both. These infections are called ...